Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

HRTSvsIHIETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
+1.34%
VS
ETF 2
IHI

iShares U.S. Medical Devices ETF

This fund is part of
US Health Care
-0.7%

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. iShares U.S. Medical Devices ETF (IHI) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Healthcare. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.38% for IHI. HRTS is up 4.32% year-to-date (YTD) with -$2M in YTD flows. IHI performs worse with -14.99% YTD performance, and -$181M in YTD flows. Run a side-by-side ETF comparison of HRTS and IHI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS vs IHI performance and flow charts

Performance

-2.00.02.04.06.08.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

-100 M-50 M0 M50 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
IHI
+1.63%+6.69%
+9.49%+3.41%
+4.32%-14.99%
+31.36%-13.79%
n/a-4.67%
n/a-15.35%
Flows
HRTS
IHI
-+$63M
-$70K+$21M
-$2M-$181M
-$6M-$545M
--$2.66B
--$3.63B
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
IHI
+17.44%+27.25%
+16.04%+20.07%
n/a+18.19%
n/a+19.62%
Max drawdown
HRTS
IHI
-4.69%-6.91%
-10.68%-26.18%
n/a-26.72%
n/a-33.07%
Max drawdown duration
HRTS
IHI
23d56d
170d247d
n/a540d
n/a1786d
Trading data

Create an account to view trading data

Join for free
HRTS
IHI
Last sale
7/31/2026 at 1:30 PM
$36.43
$52.51
Previous close
07/30/2026
$36.90
$52.74
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HRTS
IHI
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
HRTS
IHI
Last price
$36.43
$52.51
1D performance
-1.26%
-0.44%
AuM$54.92 M$3.27 B
E/R0.99%0.38%
Characteristics
HRTS
IHI
Management strategyActivePassive
ProviderTemaiShares
Benchmark-Dow Jones U.S. Select Medical Equipment Index
N° of holdings4347
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023May 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

HRTS
USA
76.55%
Switzerland
7.26%
Other
16.19%
IHI
USA
91.35%
Ireland
7.6%
Other
1.04%

Sectors

HRTS
Healthcare
99.57%
Other
0.43%
IHI
Healthcare
99.8%
Other
0.2%
Advertisement

Diversification

HRTS

Total weight of top 15 holdings out of 15

64.29%
IHI

Total weight of top 15 holdings out of 15

88.02%

Top 15 holdings

Data as of June 30, 2026
HRTS
Eli Lilly & Co.
11.91%
UnitedHealth Group, Inc.
5.58%
Novo Nordisk A/S
5.25%
Merck & Co., Inc.
4.11%
Roche Holding AG
3.96%
Thermo Fisher Scientific, Inc.
3.91%
AstraZeneca PLC
3.85%
Johnson & Johnson
3.84%
Revolution Medicines, Inc.
3.64%
Cytokinetics, Inc.
3.40%
Novartis AG
3.30%
Gilead Sciences, Inc.
3.09%
Vertex Pharmaceuticals, Inc.
3.04%
Abbott Laboratories
2.71%
Danaher Corp.
2.70%
IHI
Abbott Laboratories
16.93%
Intuitive Surgical, Inc.
15.09%
Stryker Corp.
11.64%
Edwards Lifesciences Corp.
4.75%
Becton, Dickinson & Co.
4.63%
GE Healthcare Technologies, Inc.
4.51%
Medtronic Plc
4.40%
ResMed, Inc.
4.38%
IDEXX Laboratories, Inc.
4.27%
DexCom, Inc.
4.02%
Boston Scientific Corp.
3.99%
STERIS Plc (Ireland)
3.20%
Zimmer Biomet Holdings, Inc.
2.58%
Penumbra, Inc.
1.92%
Baxter International, Inc.
1.71%
Frequently asked questions about HRTS and IHI

How have the HRTS and IHI ETFs performed in 2026?

As of July 30, 2026, HRTS is up 4.32% year-to-date (YTD), while IHI has lost -14.99%. That puts HRTS better performer ahead so far this year.

Which ETF is attracting more investor money: HRTS or IHI?

Year-to-date, the HRTS ETF saw -$2M in flows, compared to -$181M for IHI.

Which ETF is more volatile: HRTS or IHI?

Over the past year, HRTS had a volatility of 16.04%, while IHI experienced 20.07%.

Which ETF is bigger: HRTS or IHI?

As of July 30, 2026, HRTS holds $54.92 M in assets under management (AUM), while IHI manages $3.27 B.

What sectors do the HRTS and IHI ETFs invest in?

HRTS leans toward sectors like Healthcare. Meanwhile, IHI focuses on Healthcare.

What are the top holdings of the HRTS ETF and IHI ETF?

HRTS top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Novo Nordisk A/S. IHI holds in its top three: Abbott Laboratories, Intuitive Surgical, Inc. and Stryker Corp..

Which ETF is more diversified: HRTS or IHI?

HRTS holds 43 securities with 64.29% of its assets in the top 15. IHI has 47 securities and a top 15 weight of 88.02%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026